ArticleFrontiers in oncology2022

Favorable outcome of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with nonmetastatic osteosarcoma and low-degree necrosis.

Kyung Taek Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.